• Crinetics Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference

    来源: Nasdaq GlobeNewswire / 07 6月 2022 07:30:00   America/New_York

    SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that company management will participate in person in a fireside chat at the annual JMP Securities Life Sciences Conference, which is being held at the Lotte New York Palace on June 15-16, 2022.

    Details of the fireside chat are as follows:
    Date:Wednesday, June 15, 2022
    Time:3:30 p.m. Eastern Time
    Webcast Link:https://wsw.com/webcast/jmp54/crnx/1693872

    In addition, the live and archived presentation will be accessible on the Events & Presentations page in the Investors section on the Company’s website.

    About Crinetics Pharmaceuticals
    Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Currently, paltusotine is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. Crinetics has demonstrated pharmacologic proof-of-concept in Phase 1 clinical studies for CRN04777, a somatostatin receptor type 5 (SST5) agonist for congenital hyperinsulinism and CRN04894, an ACTH antagonist for the treatment of congenital adrenal hyperplasia, Cushing’s disease and other diseases of excess ACTH. All of the company’s drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts.

    Contacts:
    Chas Schultz
    VP, IR & Corporate Communications
    cschultz@crinetics.com
    (858) 450-6464

    Investors / Media:
    Corey Davis
    LifeSci Advisors, LLC
    cdavis@lifesciadvisors.com
    (212) 915-2577

    Aline Sherwood
    Scienta Communications
    asherwood@scientapr.com
    (312) 238-8957


    Primary Logo

分享